OPNT - Opiant Pharmaceuticals Inc. (OPNT) CEO Roger Crystal On Q4 2021 Results - Earnings Call Transcript
Opiant Pharmaceuticals, Inc. (OPNT) Q4 2021 Earnings Conference Call March 15, 2022 4:30 PM ET Company Participants Ben Atkins - Vice President, Communications and Investor Relations Roger Crystal - President and Chief Executive Officer Matt Ruth - Chief Commercial Officer David O'Toole - Chief Financial Officer Conference Call Participants Brandon Folkes - Cantor Fitzgerald Carl Byrnes - Northland Capital Markets David Bautz - Zacks Disclaimer*: This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide. Presentation Operator 00:03 Greetings, and welcome to the Opiant Pharmaceuticals Fourth Quarter and Full-Year 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. A brief question-and-answer session will follow the formal presentation. [Operator
For further details see:
Opiant Pharmaceuticals, Inc. (OPNT) CEO Roger Crystal On Q4 2021 Results - Earnings Call Transcript